Global Gastritis Treatment Market Is Estimated To Witness High Growth Owing To Growing Prevalence Of Gastrointestinal Disorders And Rising Rate Of Drug Approvals And Launches
Gastritis Treatment Market |
Overview:
If case of Chronic Gastritis, doctors will recommend lifestyle changes to
reduce symptoms and help the stomach lining heal. These may include eating
smaller meals, avoiding spicy or acidic foods, and not lying down after eating.
Drinking plenty of water and avoiding alcohol are also helpful. These medicines
neutralize stomach acid and relieve pain. They can be found over the counter,
such as famotidine (Pepcid), or prescription, such as lansoprazole (Prevacid)
and omeprazole (Prilosec). Steady
use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) irritate the
stomach lining. Some types of cancer treatments can also trigger gastritis,
especially chemotherapies that are given by mouth. Excessive alcohol can
irritate and erode the stomach lining. Stress also can bring on gastritis.
Severe physical trauma, such as a car accident or severe burns, can also cause
gastritis.
Market
Dynamics:
Rising research
and developmental activities are estimated to augment growth of the global Gastritis
Treatment Market during the forecast period. For
instance, MArinomed Biotech has
developed a new drug for treating autoimmune gastritis in October 2020. The
company is aiming to focus on the anti-inflammatory treatment instead of
treating the deficiency symptoms. Moreover, rising cost of treatments and
unavailability of appropriate treatments are anticipated to
restrain growth of the
global gastritis treatment market during
the forecast period.
Impact
of COVID-19:
The outbreak was
first reported in 2019 and then it was transmitted to all parts of the world.
The pandemic had a significant impact on all individuals. However, people
suffering from gastrointestinal disorders were severely affected. As the early
symptoms of gastrointestinal diseases like diarrhea, abdominal pain, and
vomiting, were also witnessed in people suffering from COVID-19. Therefore,
diagnosing these symptoms that further led to respiratory problems was a major
concern. This led to increase in demand for gastritis treatments during the pandemic. This had a
positive impact on the growth of the global gastritis treatment market.
Key
Takeaways:
The
global Gastritis Treatment Market is expected to
witness robust growth, exhibiting CAGR of 3.67 %
over the forecast period, due to growing acquisitions. For instance, AstraZeneca
acquired CinCor Pharma Inc., in January 2023, for 1.8 Billion. This acquisition
will support in accelerating AstraZeneca’s cardio renal and chronic kidney
disease treatments.
North America is anticipated to
witness robust growth in the global gastritis treatment market during
the forecast period, due to growing prevalence
of gastritis and increasing unhealthy lifestyles of the population.
Key
players active in the global Gastritis Treatment Market are Zydus Group, F. Hoffmann-La Roche
Ltd., Lupin, Mylan N.V., Endo International plc, Teva Pharmaceutical Industries
Ltd., Dr. Reddy's Laboratories Ltd, Sanofi, Amgen Inc., Pfizer Inc., Lilly, GSK
plc, Merck & Co., Inc., Novartis AG, Sun Pharmaceutical Industries Ltd.,
AstraZeneca, and Johnson & Johnson Private Limited.
Comments
Post a Comment